DOI QR코드

DOI QR Code

미만성 거대B세포 항암치료 중 유발된 주기적 저칼륨성 마비 1예

Glucocorticoid Triggers an Attack of Periodic Hypokalemic Paralysis during Treatment for Diffuse Large B-cell Lymphoma

  • 하경선 (가톨릭대학교 의과대학 내과학교실) ;
  • 박영재 (가톨릭대학교 의과대학 내과학교실) ;
  • 박성수 (가톨릭대학교 의과대학 내과학교실) ;
  • 이준엽 (가톨릭대학교 의과대학 내과학교실) ;
  • 김지현 (가톨릭대학교 의과대학 내과학교실) ;
  • 장인애 (가톨릭대학교 의과대학 내과학교실) ;
  • 변재호 (가톨릭대학교 의과대학 내과학교실)
  • Ha, Kyung Sun (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Park, Young Jae (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Park, Sung Soo (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Lee, Joon Yub (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Kim, Ji Hyun (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Jang, Inae (Department of Internal Medicine, The Catholic University College of Medicine) ;
  • Byun, Jae Ho (Department of Internal Medicine, The Catholic University College of Medicine)
  • 투고 : 2013.11.20
  • 심사 : 2014.03.29
  • 발행 : 2014.11.01

초록

이번 증례는 드문 예지만 항암치료를 위해 투여한 스테로이드가 주기적 저칼륨성 마비의 유발 인자로 작용할 수 있음을 보여준다. 미만성 거대B세포 림프종의 치료 중 주기적 저칼륨성 마비가 있는 경우 칼륨 수치에 대한 측정과 칼륨 보충이 필요하다.

Hypokalemic periodic paralysis is a rare disorder characterized by sudden onset of weakness and low serum potassium levels. We report a case provoked by combination chemotherapy including prednisolone. A 23-yr-man, diagnosed with diffuse large B-cell lymphoma, received chemotherapy. He developed significant weakness in upper and lower extremities during chemotherapy, and his serum potassium level was 1.7 mmol/L. Potassium replacement restored the weakness. Further workup revealed that prednisolone had provoked hypokalemic paralysis. As prednisolone triggered an attack of hypokalemic periodic paralysis, it should be administered with caution, particularly in patients with periodic paralysis.

키워드

참고문헌

  1. Finsterer J. Primary periodic paralyses. Acta Neurol Scand 2008;117:145-158. https://doi.org/10.1111/j.1600-0404.2007.00963.x
  2. Fontaine B, Fournier E, Sternberg D, Vicart S, Tabti N. Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder. Neurotherapeutics 2007;4:225-232. https://doi.org/10.1016/j.nurt.2007.01.002
  3. Wongraoprasert S, Buranasupkajorn P, Sridama V, Snabboon T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med 2007;46:1431-1433. https://doi.org/10.2169/internalmedicine.46.0044
  4. Sternberg D, Tabti N, Hainque B, Fontaine B. Hypokalemic Periodic Paralysis. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, eds. GeneReviews R[Internet]. Seattle(WA): University of Washington, 2002
  5. Streeten DH, Speller PJ, Fellerman H. Use of corticotropin- induced potassium changes in the diagnosis of both hypo- and hyperkalemic periodic paralysis. Eur Neurol 1993;33:103-108. https://doi.org/10.1159/000116914
  6. Brillon DJ, Zheng B, Campbell RG, Matthews DE. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol 1995;268:E501-513.
  7. Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 2004;26:157-161. https://doi.org/10.1016/j.jemermed.2003.05.004
  8. Ikeda K, Iwasaki Y, Kinoshita M, et al. Acetazolamide- induced muscle weakness in hypokalemic periodic paralysis. Intern Med 2002;41:743-745. https://doi.org/10.2169/internalmedicine.41.743
  9. Arzel-Hezode M, McGoey S, Sternberg D, Vicart S, Eymard B, Fontaine B. Glucocorticoids may trigger attacks in several types of periodic paralysis. Neuromuscul Disord 2009;19:217-219. https://doi.org/10.1016/j.nmd.2008.12.008
  10. Miyashita Y, Monden T, Yamamoto K, et al. Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis. Intern Med 2006;45:11-13. https://doi.org/10.2169/internalmedicine.45.1495